ArticleActa gastroenterologica Latinoamericana
[Prevalence of Helicobacter pylori and Endoscopic and Histopathological Fin-dings in Obese Patients who are Can-didates for Bariatric Surgery].
Article in Acta gastroenterologica Latinoamericana. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The prevalence of Helicobacter pylori in obese patients has been poorly documented, especially in contexts with adequate healthcare access. In these patients, the absence of visible lesions during endoscopy may lead to underestimate relevant histological alterations if systematic biopsies are not performed. There are few local studies characterizing this population, which motivates the need for this research. Objective: To estimate the prevalence of Helicobacter pylori and to describe the endoscopic and histopathological findings, as well as sociodemographic variables, in obese patients who are candidates for bariatric surgery at the Hospital Universitario Austral. Materials and methods: Observational, descriptive, cross-sectional, and retrospective study carried out on a cohort of patients who underwent bariatric surgery between 2022 and 2024. Those with complete esophagogastroduodenoscopy) and gastric biopsies according to the Sydney protocol were included. Endoscopic findings, histopathological diagnosis, and the presence or absence of H. pylori in the patients were analyzed, stratified by sex and degree of obesity. Results: Out of the 418 patients who underwent surgery in our institution, 326 (78%) with esophagogastroduodenoscopy with gastric biopsies were included in the analysis. The rest had esophagogastroduodenoscopy without biopsies, or had not undergone the procedure. Endoscopic lesions were identified in 60.1% of cases, the most frequent being gastric erosions (35.5%) and erosive esophagitis (18.1%). The histopathological analysis revealed chronic gastritis in 55.2% and Helicobacter pylori infection in 21.5%, even in the absence of macroscopic lesions. Significant differences by sex were observed in the prevalence of lesions and histological findings. Conclusion: The systematic use of biopsies according to Sydney's protocol allows the identification of relevant histological alterations in obese patients, even in the absence of apparent endoscopic lesions. It is important to perform systematic biopsies during preoperative evaluation to optimize the detection and timely treatment of associated gastrointestinal pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.